Pipeline
Nymox is developing novel, safe and proprietary treatments targeting large markets and expanding markets in a rapidly aging population. Nymox’ unique, advanced product candidates address significant unmet medical needs for better treatment options in the indications they are being developed for.
Press releases
March 27, 2024
Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages